Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
PharmaCorp RxTSXV:PCRX 36 PB Ratio is 1.66 as of Jul. 15, 2026, which is 10% below its 10-year median of 1.85. GuruFocus rates TSXV:PCRX with a GF Score™ of 36/100. The stock has 2 warning signs investors should review. Among 611 Healthcare Providers & Services companies, PharmaCorp Rx ranks better than 59.25% on this metric.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2026-07-15), PharmaCorp Rx's share price is C$0.50. PharmaCorp Rx's Book Value per Share for the quarter that ended in Mar. 2026 was C$0.30. Hence, PharmaCorp Rx's PB Ratio of today is 1.66.
The historical rank and industry rank for PharmaCorp Rx's PB Ratio or its related term are showing as below:
TSXV:PCRX'
s PB Ratio Range Over the Past 10 Years
Min: 0.91 Med: 1.85 Max: 3.02
Current: 1.66
During the past 5 years, PharmaCorp Rx's highest PB Ratio was 3.02. The lowest was 0.91. And the median was 1.85.
TSXV:PCRX's PB Ratio is ranked better than 59.25% of 611
companies
in the Healthcare Providers & Services industry
Industry Median: 2.02
vs TSXV:PCRX: 1.66
During the past 12 months, PharmaCorp Rx's average Book Value Per Share Growth Rate was 15.30% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was 63.60% per year.
During the past 5 years, the highest 3-Year average Book Value Per Share Growth Rate of PharmaCorp Rx was 121.00% per year. The lowest was 63.60% per year. And the median was 92.30% per year.
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
PharmaCorp Rx PB Ratio Related Terms
PharmaCorp Rx PB Ratio Historical Data
* Premium members only.
The historical data trend for PharmaCorp Rx's PB Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Pharmaceutical Retailers subindustry, PharmaCorp Rx's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
PharmaCorp Rx PB Ratio vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, PharmaCorp Rx's PB Ratio distribution charts can be found below:
* The bar in red indicates where PharmaCorp Rx's PB Ratio falls into.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
PharmaCorp Rx's PB Ratio for today is calculated as follows:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
PharmaCorp Rx (TSXV:PCRX) has a PB Ratio of 1.66 as of Jul. 15, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on PharmaCorp Rx and its competitors. This is 10% below median its historical median of 1.85. Over the past decade, PharmaCorp Rx's PB Ratio has ranged from 0.91 to 3.02. According to the industry distribution chart, PharmaCorp Rx ranks #249 out of 611 companies in the Healthcare Providers & Services industry, placing it in the top 40.8%.
Is PharmaCorp Rx's PB Ratio too high?
PharmaCorp Rx's current PB Ratio of 1.66 is 10% below median its 10-year median of 1.85. Over the past 10 years, this metric has ranged from a low of 0.91 to a high of 3.02. The Healthcare Providers & Services industry median PB Ratio is 2.02. PharmaCorp Rx's value of 1.66 is 17.8% below this industry median. Based on the distribution chart, PharmaCorp Rx ranks #249 out of 611 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, PharmaCorp Rx has a GF Score™ of 36/100, reflecting its overall financial health beyond just this single metric.
How does PharmaCorp Rx's PB Ratio compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, PharmaCorp Rx ranks #249 out of 611 companies for PB Ratio. This puts PharmaCorp Rx in the upper half of its industry. The industry median PB Ratio is 2.02. PharmaCorp Rx's value of 1.66 is 17.8% below this benchmark. Historically, PharmaCorp Rx's own PB Ratio has ranged from 0.91 to 3.02 over the past decade. While the company's 10-year median is 1.85 vs. the industry median of 2.02, PharmaCorp Rx has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Healthcare Providers & Services company?
The median PB Ratio among Healthcare Providers & Services companies is 2.02, based on 611 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. PharmaCorp Rx's current PB Ratio of 1.66 is 17.8% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on PharmaCorp Rx and its competitors. For the Healthcare Providers & Services industry, the median PB Ratio is 2.02 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. PharmaCorp Rx's current PB Ratio is 1.66, which is 10% below median its own 10-year median of 1.85. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PharmaCorp Rx stock overvalued right now?
PharmaCorp Rx (TSXV:PCRX) has a current PB Ratio of 1.66. The current PB Ratio is 1.66, which is 10% below median its 10-year median of 1.85 and 17.8% below the Healthcare Providers & Services industry median of 2.02. PharmaCorp Rx's overall GF Score™ is 36/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For PharmaCorp Rx (TSXV:PCRX), the current PB Ratio is 1.66 as of Jul. 15, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
PharmaCorp Rx Inc operates three PharmaChoice bannered pharmacies in Canada and will continue to acquire PharmaChoice Canada-branded pharmacies as it come to market in conjunction with its strategic alliance agreement with PharmaChoice Canada. The company will also acquire independently owned non-PharmaChoice Canada-bannered pharmacies in Canada, and thereafter, continue to operate such acquired pharmacies under a PharmaChoice Canada banner.
36GF Score
Get the complete analysis for TSXV:PCRX
PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSXV:PCRX has been successfully added to your 
